BRCA1 and BRCA2
BRCA1: Brca1; BRCA1/BRCA2-containing complex, subunit 1; BRCAI; BRCC1; Breast and ovarian cancer susceptibility protein 1; Breast cancer 1; Breast cancer 1, early onset; Breast cancer type 1 susceptibility protein; Breast cancer type 1 susceptibility protein homolog; IRIS; PSCP; RING finger protein 53; RNF53
BRCA2: BRCA1/BRCA2-containing complex, subunit 2; Brca2; BRCC2; Breast and ovarian cancer susceptibility gene, early onset; Breast cancer 2; Breast cancer 2 tumor suppressor; Breast cancer 2, early onset; Breast cancer susceptibility protein BRCA2; Breast cancer type 2 susceptibility protein homolog; FACD; FAD; FAD1; FANCB; FANCD; Fancd1; Fanconi anemia group D1 protein; Fanconi anemia group D1 protein homolog; RAB163
Most breast and ovarian cancers (BOC) are sporadic, meaning they occur by chance with no known cause. A diagnosis of hereditary breast and ovarian cancer syndrome (HBOC) has been considered when multiple...
- Solano AR, Aceto GM, Delettieres D, Veschi S, Neuman MI, Alonso E, et al. BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin. Springerplus. 2012;1:20.PubMedPubMedCentralCrossRefGoogle Scholar
- Solano AR, Cardoso FC, Romano V, Perazzo F, Bas C, Recondo G, Santillan FB, Gonzalez E, Abalo E, Viniegra M, Michel JD, Nuñez LM, Noblia CM, Mc Lean I, Canton ED, Chacon RD, Cortese G, Varela EB, Greco M, Barrientos ML, Avila SA, Vuotto H, Lorusso A, Podesta EJ, Mando OG. Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice. Oncotarget. 2016. doi:10.18632/oncotarget.10814.Google Scholar